Seeing Is Believing
Currently out of the existing stock ratings of Bradley Canino, 65 are a BUY (77.38%), 19 are a HOLD (22.62%).
Analyst Bradley Canino works at STIFEL with a stock forecast success ratio of 39.6% fulfilled within 94.25 days on average.
Bradley Canino’s has documented 165 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MRUS, Merus BV at 29-Feb-2024.
Analyst best performing recommendations are on NUVL (NUVALENT).
The best stock recommendation documented was for ARVN (ARVINAS) at 11/8/2023. The price target of $42 was fulfilled within 49 days with a profit of $25.49 (154.39%) receiving and performance score of 31.51.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
20
$8.59 (75.28%)
17.5
18 days ago
1/5 (20%)
$6.54 (48.59%)
188
Buy
18
$6.59 (57.76%)
3 months 21 days ago
1/5 (20%)
$5.74 (46.82%)
93
Buy
10
$-1.41 (-12.36%)
15
4 months 15 days ago
3/6 (50%)
$1.17 (13.25%)
265
Buy
11
$-0.41 (-3.59%)
8
5 months 18 days ago
4/4 (100%)
$1.91 (21.01%)
54
Buy
27
$15.59 (136.63%)
5 months 25 days ago
0/2 (0%)
$20.62 (323.20%)
Which stock is Bradley Canino is most bullish on?
Which stock is Bradley Canino is most reserved on?
What Year was the first public recommendation made by Bradley Canino?